GlobeNewsWire
06 Nov 2025, 21:05 UTC · 50w ago
Elutia Reports Third Quarter 2025 Financial Results; Closes $88 Million Sale of BioEnvelope Business to Boston Scientific Corporation; Funds NXT-41x Development
Verdict
Headline takes no side. We score ELUT +0.60 — strongly bullish.
- Expected · ELUT
+0.60strongly bullish
−1 bearish0bullish +1More positive than 78% of ticker scores this week





